Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins…
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox…
Merial - maker of the canine NSAID Previcox - has launched a campaign to raise awareness of the prevalence of canine osteoarthritis amongst dog owners in the UK.
Previcox Product Manager Claire Edmunds said: "We know that approximately 20% of adult dogs…
Merial has launched Supleneo flex, a nutraceutical supplement designed to be part of a Total Joint Health programme for dogs, administered once daily.
Merial says the new product supports its market position as a leading force in canine pain management,
Merial Animal Health has announced that it has purchased the the anti-inflammatory treatment for lameness in horses, Hyonate® (sodium hyaluronate), from Bayer.
Merial's equine marketing and technical manager, Louise Radford MRCVS said: "Hyonate is…
Merial is highlighting the results of an independent study published in July's Journal of Dairy Science which showed that treating acutely lame cows with the non-steroidal anti-inflammatory (NSAID) Ketofen (ketoprofen), alongside therapeutic trimming…